Abstract Details

Title Antibodies to neuronal surface antigens in possible autoimmune encephalitis and new-onset refractory status epilepticus (NORSE)

Topic Epilepsy/Clinical Neurophysiology (EEG)

Presentation(s) S21 - (-)

Poster/Presentation
Number 007

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Takahiro Iizuka, MD (Department of Neurology, Kitasato University School of Medicine) PRESENTER	The institution of Dr. Iizuka has received research support from Astellas Pharma Inc.
Juntaro Kaneko	Juntaro Kaneko has nothing to disclose.
	No disclosure on file
Naomi Kanazawa	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Yoshihiro Sugiura, MD, PhD (Fukushima National Hospital)	No disclosure on file
	No disclosure on file
Masashi Watanabe, MD (Ehime Prefectural Central Hospital)	Dr. Watanabe has nothing to disclose.
	No disclosure on file
	No disclosure on file
Atsushi Kaneko	No disclosure on file
	No disclosure on file
Eiji Kitamura	No disclosure on file
Josep O. Dalmau, MD, PhD, FAAN	Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care.
Kazutoshi Nishiyama, MD, PhD	Kazutoshi Nishiyama, MD, PhD has nothing to disclose.